(Q38297001)

1 September 2017

title

A growth factor antagonist as a targeting agent for sterically stabilized liposomes in human small cell lung cancer (English)

1 reference

ORCID Public Data File 2021

1 September 2017

1 reference

1 reference

author name string

J N Moreira

1

1 reference

1 September 2017

C B Hansen

2

1 reference

1 September 2017

R Gaspar

3

1 reference

1 September 2017

T M Allen

4

1 reference

1 September 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Biochimica et Biophysica Acta

1 September 2017

published in

1 reference

1 September 2017

volume

1514

1 reference

1 September 2017

issue

2

1 reference

1 September 2017

page(s)

303-317

1 reference

[Arg6,D-Trp7,9,NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Preclinical studies on the broad-spectrum neuropeptide growth factor antagonist G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

[D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Metabolism of the anticancer peptide H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Characterization of the deamidase enzyme responsible for the metabolism of the anticancer peptide: H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Pharmacokinetics, metabolism, tissue and tumour distribution of the neuropeptide growth factor antagonist [Arg6, D-Trp7,9, NmePhe8]- substance P(6-11) in nude mice bearing the H69 small-cell lung cancer xenograft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Pharmacokinetics of stealth versus conventional liposomes: effect of dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Cellular Trafficking and Cytotoxicity of Anti-Cd19-Targeted Liposomal Doxorubicin in B Lymphoma Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Noninvasive gene targeting to the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Development of anti-p185HER2 immunoliposomes for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Immunoliposomes for cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

125I labelled inulin: a convenient marker for deposition of liposomal contents in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Novel preparation method of immunogen for hydrophobic hapten, enzyme immunoassay for daunomycin and adriamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

[D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P induces apoptosis in lung cancer cell lines in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Correlations between the rate of intracellular release of endocytosed liposomal Doxorubicin and cytotoxicity as determined by a new assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Hormone production by cultures of small-cell carcinoma of the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Flip-flop of doxorubicin across erythrocyte and lipid membranes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Internalization of V2-vasopressin receptors in LLC-PK1-cells: evidence for receptor-mediated endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Agonist and antagonist-dependent internalization of the human vasopressin V2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Vasopressin receptor-mediated endocytosis in cells transfected with V1-type vasopressin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

A serine cluster prevents recycling of the V2 vasopressin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Transient phosphorylation of the V1a vasopressin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Induction of immune response against a short synthetic peptide antigen coupled to small neutral liposomes containing monophosphoryl lipid A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Suppression of GD1alpha ganglioside-mediated tumor metastasis by liposomalized WHW-peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Peptide attachment to extremities of liposomal surface grafted PEG chains: preparation of the long-circulating form of laminin pentapeptide, YIGSR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Neurohypophyseal Hormone Receptors in the Rat Thymus, Spleen, and Lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Extrapituitary expression of the rat V1b vasopressin receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

Clinical efficacy and prospects for use of pegylated liposomal doxorubicin in the treatment of ovarian and breast cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900386-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0005-2736(01)00386-8

1 reference

1 September 2017

1 reference